Overview

Combination Therapy for the Treatment of Bipolar Disorders

Status:
Terminated
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This study will compare triple and double drug regimens in the treatment of patients with depression, hypomania, or mania.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Anticonvulsants
Lamotrigine
Lithium Carbonate
Valproic Acid